With the rapid transformation and the global growth of clinical trials, controlling the cost and achieving more effective investment of the resources that small star...

Clinical trial insurance is intended to compensate patientvolunteers (“volunteers”) in a clinical trial (or their dependents) for death or injury arising out of thei...

The push by pharma companies to develop more targeted compounds in response to unmet medical needs, and the large return on investment these successful therapies gen...

The global pharmaceutical industry has entered an exciting new era of drug development, bringing new hope to patients around the world. It is estimated that close to...

Any issues in the recruitment and retention of subjects for a clinical trial can result in delays and unnecessary costs, and may even potentially undermine its resul...

Although Duchenne Muscular Dystrophy (DMD) is a rare disease, multiple targets are being pursued to find treatments. As a result, DMD patients have several options w...

Patients with diabetes have an up to 50% increased risk of cardiovascular (CV) disease (CVD) compared to individuals without diabetes. Optimisation of glycaemic cont...

The use of biomarkers which assist in understanding various therapeutic medical diseases has applications in observational, randomised clinical trials, screening and...

From early-stage studies to global, late-stage trials, oncology research is expanding at a rapid rate, and this advancing innovation has resulted in increasingly com...

Prior to the creation of any outreach programme, the social media landscape can be analysed to ensure the content and language of engagement resonates with patients ...